BIT 5.26% 2.0¢ biotron limited

Have Merck beaten us to the punch?, page-9

  1. 3,586 Posts.
    lightbulb Created with Sketch. 331
    Good to see Merck has found away to make money out of Ivermectin after all, all they had to do was re-brand it to Molnupiravir and Bobs your uncle.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.